Calastone: Vaccine causes second highest equity flows ever

April remains top month for equity inflows

clock • 2 min read

The breakthrough of a vaccine for Covid-19 sparked the second highest month of equity fund flows on record, according to new data from Calastone.

This boost to investors' confidence meant equity inflows of £2.3bn were registered in November, making this second highest month of equity fund flows on record. The highest month of equity inflows remains April 2020 when investors poured a net £2.7bn into these funds. Covid-19 prompts transactions surge across Calastone network Calastone's daily trading data shows that, in the five days prior to Pfizer's announcement of a vaccine breakthrough, equity funds experienced outflows of £389m. In the five days after this announcement, equity funds received inflows totalling £1.4bn. ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Funds

Trustpilot